Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Data Domain, Inc. | 10,947,664 | reported | 24 Dec 2007 | tx 1−887,648 |
| ZHONE TECHNOLOGIES INC | 8,940,337 | reported | 10 Mar 2008 | tx 154+8,914,689 |
| Workday, Inc. | 6,963,636 | reported | 17 Oct 2012 | tx 2+6,963,636−6,963,636 |
| ZHONE TECHNOLOGIES INC | 5,956,205 | reported | 13 Nov 2003 | tx 5+12,831,205−25,662,410 |
| GLU MOBILE INC | 5,919,443 | reported | 08 Aug 2011 | tx 4+1,500,000−375,000 |
| Neutral Tandem Inc | 4,846,185 | reported | 18 Aug 2008 | tx 1−600,000 |
| IOMAI CORP | 4,844,228 | reported | 25 Oct 2006 | tx 5+4,844,228−39,455,340 |
| GYRE THERAPEUTICS, INC. | 4,563,512 | reported | 17 Jan 2008 | tx 6+4,564,512−20,227,034 |
| INNERWORKINGS INC | 4,529,190 | reported | 28 Mar 2012 | tx 20+27,759−3,608,423 |
| PHARMION CORP | 4,341,268 | reported | 05 Nov 2003 | tx 1+400,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | |
| 24 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,977 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 2,989 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15,000 | 12.98 USD | |
| 21 Nov 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 09 Oct 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 1,200 | 51.55 USD | |
| 09 Oct 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 23,800 | 50.73 USD | |
| 27 Aug 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 3,588 | 45.01 USD | |
| 25 Aug 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 1,000 | 45.00 USD | |
| 22 Aug 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 1,412 | 45.00 USD | |
| 22 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | |
| 22 Feb 2025 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | deriv |
| 19 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 7,296 | 0.00 USD | deriv |
| 19 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | deriv |
| 11 Nov 2024 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 20,000 | 9.13 USD | |
| 11 Nov 2024 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 10,700 | 36.24 USD | |
| 11 Nov 2024 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 20,000 | 0.00 USD | deriv |
| 23 Feb 2024 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3,886 | 0.00 USD | |
| 23 Feb 2024 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 3,886 | 0.00 USD | deriv |
| 22 Feb 2024 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 8,252 | 0.00 USD | deriv |
| 22 Feb 2024 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | deriv |
| 16 Nov 2023 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 7,457 | 9.24 USD | |
| 16 Nov 2023 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 2,500 | 28.01 USD | |
| 16 Nov 2023 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 7,457 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 07 Mar 2012.